Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Nina Bacher"'
Autor:
Albert Topf, Moritz Mirna, Nina Bacher, Vera Paar, Lukas J. Motloch, Bernhard Ohnewein, Robert Larbig, Janine Grueninger, Uta C. Hoppe, Michael Lichtenauer, Rudin Pistulli
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Introduction: Among the causes of de novo diagnosed cardiomyopathy, Takotsubo cardiomyopathy (TTC) plays a minor role, with an occurrence of 50,000–100,000 cases per annum in the United States. In clinical practice, a differentiation of a TTC towar
Externí odkaz:
https://doaj.org/article/53e0330916074cb5a921f2d76ef26203
Autor:
Albert Topf, Moritz Mirna, Nina Bacher, Lukas Schmutzler, Peter Jirak, Bernhard Ohnewein, Uta C. Hoppe, Michael Lichtenauer
Publikováno v:
Life, Vol 12, Iss 6, p 788 (2022)
Introduction: Takotsubo cardiomyopathy (TTC) and acute coronary syndrome (ACS) are clinically indistinguishable from each other. Although therapeutically redundant, coronary angiography remains indispensable for differential diagnosis. Methods: In ou
Externí odkaz:
https://doaj.org/article/4bb0c5a9d311400ebee20e67224d7e9b
Autor:
Elke Boxhammer, Moritz Mirna, Laura Bäz, Nina Bacher, Albert Topf, Brigitte Sipos, Marcus Franz, Daniel Kretzschmar, Uta C. Hoppe, Alexander Lauten, Michael Lichtenauer
Publikováno v:
Life, Vol 12, Iss 3, p 389 (2022)
Background: Severe aortic valve stenosis (AS) is associated with pulmonary hypertension (PH) and has been shown to limit patient survival. Soluble suppression of tumorigenicity-2 (sST2) is a cardiovascular biomarker that has proven to be an important
Externí odkaz:
https://doaj.org/article/ba74d38b58f842e9a7dbed3a238a96c4
Autor:
Albert Topf, Moritz Mirna, Christiane Dienhart, Peter Jirak, Nina Bacher, Elke Boxhammer, Sarah X. Gharibeh, Lukas J. Motloch, Uta C. Hoppe, Michael Lichtenauer
Publikováno v:
Biomedicines, Vol 10, Iss 2, p 464 (2022)
Introduction: Treatment with betablockers is controversial in Takotsubo syndrome (TTS); however, many physicians intuitively initiate or continue betablocker therapy in these patients. The effect of preadmission betablocker use on adverse cardiovascu
Externí odkaz:
https://doaj.org/article/444501ac620c4b17819675e63086fc29
The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
Autor:
Albert Topf, Moritz Mirna, Nina Bacher, Vera Paar, Christoph Edlinger, Lukas J. Motloch, Sarah Gharibeh, Marwin Bannehr, Uta C. Hoppe, Michael Lichtenauer
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 10, p 127 (2021)
Introduction: Takotsubo cardiomyopathy (TTC) remains a life-threatening disease with the risk of decompensated heart failure and arrhythmias. Valid markers for the prediction of outcome are unavailable. The novel biomarkers fetuin-A, matrix metallopr
Externí odkaz:
https://doaj.org/article/44609bf1b6254a4e9ece2c9a9b9becd4
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2000 Jan . 97(2), 565-570.
Externí odkaz:
https://www.jstor.org/stable/121662
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 1998 Nov . 95(24), 14106-14111.
Externí odkaz:
https://www.jstor.org/stable/46497
Autor:
Uta C. Hoppe, Lukas J. Motloch, Moritz Mirna, Robert Larbig, Albert Topf, Rudin Pistulli, Michael Lichtenauer, Bernhard Ohnewein, Nina Bacher, Janine Grueninger, Vera Paar
Publikováno v:
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Introduction: Among the causes of de novo diagnosed cardiomyopathy, Takotsubo cardiomyopathy (TTC) plays a minor role, with an occurrence of 50,000–100,000 cases per annum in the United States. In clinical practice, a differentiation of a TTC towar
The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
Autor:
Nina Bacher, Christoph Edlinger, Michael Lichtenauer, Sarah X. Gharibeh, Vera Paar, Moritz Mirna, Albert Topf, Uta C. Hoppe, Lukas J. Motloch, Marwin Bannehr
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 127, p 127 (2021)
Journal of Cardiovascular Development and Disease
Volume 8
Issue 10
Journal of Cardiovascular Development and Disease
Volume 8
Issue 10
Introduction: Takotsubo cardiomyopathy (TTC) remains a life-threatening disease with the risk of decompensated heart failure and arrhythmias. Valid markers for the prediction of outcome are unavailable. The novel biomarkers fetuin-A, matrix metallopr
Autor:
Albert Topf, Moritz Mirna, Vera Paar, Lukas J. Motloch, Nina Bacher, Marcus Franz, Uta C. Hoppe, Daniel Kretzschmar, Michael Lichtenauer
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 11; Pages: 2974
Introduction: Takotsubo syndrome (TTS) is clinically indistinguishable from an ACS. Despite the implementation of clinical scoring systems and novel biomarkers, coronary angiography currently remains necessary for differential diagnosis. Methods: 93